Skip to content

Guaiacum officinale and Individualized Homoeopathic medicine in the treatment of Growing pains aged between 3 and 12 years

Assessing the effectiveness of Guaiacum officinale and Individualized Homoeopathic medicine in the management of Growing Pains in Paediatric subjects A comparative study - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/102510
Enrollment
90
Registered
2026-01-30
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R298- Other symptoms and signs involvingthe nervous and musculoskeletal systems

Interventions

Intervention1: Guaiacum officinale: To assess the effectiveness of Guaiacum officinale in the management of Growing pains in age group 3 to 12 years Dosage and frequency depends upon the susceptibili

Sponsors

Dr AM AISHWARYA SRI
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subject parents/legal guardian who are willing to sign the written consent from their child to participate voluntarily and assent of the child more than 7 years of age Subjects aged between 3-12 years of age group Subjects newly diagnosed cases of growing pain according to Peterson criteria

Exclusion criteria

Exclusion criteria: Subjects suffering from Juvenile idiopathic arthritis, Osteomyelitis, Orthopedic disorders. Subjects who have low serum calcium level.

Design outcomes

Primary

MeasureTime frame
Disappearance of symptoms of Growing Pains Repetition and frequency depends on susceptibility of patientsTimepoint: 3 months

Secondary

MeasureTime frame
Reduction of symptoms of Growing pains by the end of 6 monthsTimepoint: Bythe end of 6 months

Countries

India

Contacts

Public ContactDr AM AISHWARYA SRI

Government Homoeopathic Medical College and hospital

aishusri1130@gmail.com8825788177

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026